Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
基本信息
- 批准号:10625460
- 负责人:
- 金额:$ 26.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-10 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:Abnormal HemoglobinsAcuteAddressAdolescenceAdolescentAdoptionAdultAdvocacyAffectAfricaAfrica South of the SaharaAfricanAgreementAnalgesicsAreaBenchmarkingBlood TransfusionCapitalCaringCephalicCessation of lifeChildChronicCitiesClinicClinicalCoagulation ProcessCohort StudiesConsentCountryDataDecision MakingDiseaseDisease ManagementElectronicsEndotheliumEnrollmentErythrocytesEthicsEtiologyEventFutureGenesGenetic DiseasesGenotypeGhanaGoalsGrantGuidelinesHarvestHealth PolicyHealthcareHematologyHemoglobinHemolytic AnemiaHereditary DiseaseHospitalsHydration statusImpaired cognitionIncidenceIndividualInfectionInfection preventionInfrastructureInterventionKidneyKidney DiseasesLaboratoriesLongevityManaged CareMedical centerMorbidity - disease rateNeonatal ScreeningNeurologicNigeriaOnline SystemsOntologyOrganOutcomePatient CarePatientsPenicillinsPharmaceutical PreparationsPhasePhenotypePneumococcal vaccinePoliciesPrenatal DiagnosisProphylactic treatmentProspective cohortProteinuriaProtocols documentationQuality of lifeRecommendationRecurrenceRegistriesRenin-Angiotensin-Aldosterone SystemResearchResource-limited settingResourcesSickle CellSickle Cell AnemiaSiteStandardizationStrokeStructureSyndromeSystemTanzaniaTrainingTransfusionVascular EndotheliumVisionWorkcare deliverycell registryclinical carecohortevidence basefeasibility testingfunctional statushydroxyureaimplementation facilitatorsimplementation researchimplementation strategyimplementation studyimprovedmHealthmortalityneurovascularoxidant stresspatient registrypoint of care testingpreventive interventionprogramsprophylacticprospectiverecruitresearch studyscreeningscreening programsicklingsociodemographicsstatisticssystemic inflammatory response
项目摘要
PROJECT SUMMARY
Sickle Cell Disease (SCD) is a recessively inherited disorder characterized by disordered hemoglobin
structure, aberrant endothelial interactions, systemic inflammation, oxidant stress, and activation of the
coagulation system. These abnormalities underlie a myriad of complications including acute vaso-occlusive
syndromes and a multi-system progressive chronic end-organ damage. Sub-Saharan Africa (SSA) bears a
disproportionately higher burden with an estimated 15 million of the world’s 25 million SCD individuals; 75%
of all babies born with SCD; & mortality rate for children under 5 range between 50%-90%. These include
absence of National control programs, dearth of basic facilities to manage patients, absence of systematic
screening for SCD, pervasive lack of implementation of evidence-based preventative interventions, cultural
misconceptions about the genesis of the disease, and lack of governmental support. By the sheer numbers
of patients in Africa, there is a potential for large volumes of clinical information to be harvested though
operational research for analyses to inform evidence-based decision-making on healthcare, as well as
healthcare policies for SCD on the continent. To this end, the Sickle Pan-African Research Consortium
(SPARCo) in 2017 started a registry across multiple sites in three countries: Ghana (an applicant for the
current U01 grant), Nigeria, and Tanzania. In the first phase of SPARCO, we established a collaborative site
in Kumasi and enrolled 2,915 SCD patients including 1,453 from our Newborn screening program into a
registry, and built capacity for future research studies. In this second phase, we have added an in-country
Satellite site in the capital city Accra, which has well developed clinical, training and research programs in
SCD, to form Ghana-SPARCO. Our overarching goal is to establish a prospective cohort of 6,000 individuals
living with SCD across the lifespan with a dual purpose of understanding: 1) the determinants of the protean
manifestations of acute and chronic complications of SCD in a resource-limited setting, and 2) to conduct
implementation research to address, surmount & integrate the best resource-based standards of clinical
care. Our vision is to establish hubs of excellence for research and care for SCD in Ghana. We will work with
the Coordinating Center to; (i) establish a harmonized patient registry to, (ii) integrate standards of care for
SCD, (iii) conduct cohort studies focusing on an assessment of burden and predictors of neurovascular, renal
and infectious complications of SCD across the lifespan & (iv) conduct implementation research studies on
newborn screening, retention of adolescence in SCD clinics & develop an implementation strategy for routine
integration of preventative interventions for SCD. Achieving these benchmarks will help establish the
infrastructure to develop a SCD in SSA Research Network.
项目摘要
镰状细胞病(SCD)是一种以血红蛋白紊乱为特征的遗传性疾病
结构,异常内皮相互作用,全身炎症,氧化应激,以及
凝血系统这些异常是无数并发症的基础,包括急性血管闭塞性
综合征和多系统进行性慢性终末器官损伤。撒哈拉以南非洲(SSA)
不成比例的高负担,全球2500万SCD患者中估计有1500万; 75%
在所有患有SCD的婴儿中,5岁以下儿童的死亡率在50%-90%之间。这些包括
缺乏国家控制方案,缺乏管理病人的基本设施,缺乏系统的
SCD筛查,普遍缺乏循证预防干预措施的实施,
对疾病起源的误解,以及缺乏政府支持。从数量上看
尽管非洲的患者中有大量的临床信息,
用于分析的业务研究,为基于证据的医疗保健决策提供信息,以及
在欧洲大陆的SCD医疗保健政策。为此,镰刀泛非研究联合会
(SPARCo)于2017年开始在三个国家的多个地点进行登记:加纳(
目前的U 01赠款)、尼日利亚和坦桑尼亚。在SPARCO的第一阶段,我们建立了一个合作网站,
在库马西,招募了2,915名SCD患者,包括1,453名来自我们的新生儿筛查项目的患者,
登记册,并为今后的研究建立能力。在第二阶段,我们增加了一个国内
位于首都阿克拉的卫星站点,在以下地区有完善的临床、培训和研究方案:
SCD,组成加纳SPARCO。我们的总体目标是建立一个6,000人的前瞻性队列
在整个生命周期中与SCD一起生活,有双重目的:1)多变的决定因素,
在资源有限的情况下,SCD的急性和慢性并发症的表现,以及2)进行
实施研究,以解决,超越和整合最佳的基于资源的临床标准
在乎我们的愿景是在加纳建立卓越的SCD研究和护理中心。我们将与
协调中心:(i)建立统一的患者登记处,(ii)整合护理标准,
SCD,(iii)开展队列研究,重点评估神经血管、肾功能损害的负担和预测因素,
及感染并发症;及(iv)就以下事宜进行研究
新生儿筛查,SCD诊所青春期的保留以及制定常规
整合SCD的预防性干预措施。达到这些基准将有助于建立
在SSA研究网络中开发SCD的基础设施。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Penicillin V prophylaxis uptake among children living with sickle cell disease in a specialist sickle cell clinic in Ghana: A cross-sectional study.
- DOI:10.1002/hsr2.953
- 发表时间:2022-11
- 期刊:
- 影响因子:2
- 作者:
- 通讯作者:
Iron stores in steady-state sickle cell disease children accessing care at a sickle cell disease clinic in Kumasi, Ghana: A cross-sectional study.
- DOI:10.1002/hsr2.934
- 发表时间:2022-11
- 期刊:
- 影响因子:2
- 作者:Amanor, Ernest;Kwarteng, Alexander;Larbi, Amma;Fordjour, Fatima Amponsah;Koranteng, Kelvin Kwaku;Sackey, David Sebbie;Bannor, Emmanuel;Osei, Francis Adjei;Mohammed, Aliyu;Ackah, Ezekiel Bonwin;Odoom, Samuel Frimpong;Nguah, Samuel Blay;Paintsil, Vivian;Osei-Akoto, Alex
- 通讯作者:Osei-Akoto, Alex
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Solomon Fiifi Ofori-Acquah其他文献
White Matter Injury in Sickle Cell Mice Is Associated with Reduced Neurocognitive Function and Activation of Astrocytes
- DOI:
10.1182/blood-2022-169094 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Rimi Hazra;Hongjan Pu;Lesley M. Foley;T. Kevin Hitchens;Lynda Little-Ihrig;Samit Ghosh;Solomon Fiifi Ofori-Acquah;Xiaoming Hu;Enrico M. Novelli - 通讯作者:
Enrico M. Novelli
Impact of Iron Supplementation in Anemic Voluntary First-Time Blood Donors-Results of a Pilot Trial in Ghana
- DOI:
10.1182/blood-2023-174351 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Yvonne Dei Adomakoh;Edeghonghon Olayemi;Lucy Asamoah-Akuoko;Bernard Appiah;Susan Telke;Catherine I. Segbefia;Tara Tancred;Seth Adu-Afarwuah;Amma A. Benneh-Akwasi Kuma;Alfred Edwin Yawson;Solomon Fiifi Ofori-Acquah;Philip Baba Adongo;Reena Ametorwo;Imelda Bates;Cavan Reilly;The BLOODSAFE Investigators - 通讯作者:
The BLOODSAFE Investigators
Enhanced Expression of Heme Oxygenase-1 (HO-1) Among Children with Sickle Cell Disease: Results of the Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Study
- DOI:
10.1182/blood-2023-189608 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Anna Sowa;William Kudzi;Vivian Paintsil;Amma A. Benneh-Akwasi Kuma;Catherine I. Segbefia;Edeghonghon Olayemi;David Adjei;Anastasia Bruce;Jeff Gruen;Ellis Owusu-Dabo;Solomon Fiifi Ofori-Acquah;The SickleGenAfrica Network - 通讯作者:
The SickleGenAfrica Network
Effectiveness of Hydroxyurea in Patients with Sickle Cell Disease in Ghana: A Population-Level, Healthcare Facilities-Based Study
- DOI:
10.1182/blood-2024-209483 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Duah Dwomoh;Daniel Nana Yaw Abankwah;Amma Benneh-Akwasi Kuma;Jonathan Spector;Jonathan Quartey;Olufolake A. Egbujo;Kwaku Marfo;Solomon Fiifi Ofori-Acquah;Justice Nonvignon - 通讯作者:
Justice Nonvignon
Utilization of Digital Applications to Support Provision of Comprehensive Sickle Cell Disease Management
- DOI:
10.1182/blood-2024-209803 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Duah Dwomoh;Daniel Nana Yaw Abankwah;Amma Benneh-Akwasi Kuma;Jonathan Spector;Jonathan Quartey;Olufolake A. Egbujo;Kwaku Marfo;Solomon Fiifi Ofori-Acquah;Justice Nonvignon - 通讯作者:
Justice Nonvignon
Solomon Fiifi Ofori-Acquah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Solomon Fiifi Ofori-Acquah', 18)}}的其他基金
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
- 批准号:
10402928 - 财政年份:2021
- 资助金额:
$ 26.86万 - 项目类别:
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
- 批准号:
10186856 - 财政年份:2021
- 资助金额:
$ 26.86万 - 项目类别:
Genetic determinants of hemolysis modifying defense in sickle cell disease
镰状细胞病溶血改变防御的遗传决定因素
- 批准号:
10240498 - 财政年份:2017
- 资助金额:
$ 26.86万 - 项目类别:
Genetic determinants of hemolysis modifying defense in sickle cell disease
镰状细胞病溶血改变防御的遗传决定因素
- 批准号:
10000996 - 财政年份:2017
- 资助金额:
$ 26.86万 - 项目类别:
Pittsburgh Undergraduate Research Diversity Program (PURDIP)
匹兹堡本科生研究多样性计划(PURDIP)
- 批准号:
9017260 - 财政年份:2016
- 资助金额:
$ 26.86万 - 项目类别:
Pittsburgh Undergraduate Research Diversity Program (PURDIP)
匹兹堡本科生研究多样性计划(PURDIP)
- 批准号:
10360902 - 财政年份:2016
- 资助金额:
$ 26.86万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 26.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 26.86万 - 项目类别:
Operating Grants